ScholarIQanswers from OpenAlex
Pembrolizumab for the treatment of non-small cell lung cancer
PaperCitations, authors & open-access status
Pembrolizumab for the treatment of non-small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Pembrolizumab for the treatment of non-small cell lung cancer have?
ScholarIQcitation count
Pembrolizumab for the treatment of non-small cell lung cancer has 293 citations in the OpenAlex counts ScholarIQ stores.
When was Pembrolizumab for the treatment of non-small cell lung cancer published?
ScholarIQyear
Pembrolizumab for the treatment of non-small cell lung cancer has 2016 year in the ScholarIQ index.
What is the open-access status of Pembrolizumab for the treatment of non-small cell lung cancer?
ScholarIQoa status
Pembrolizumab for the treatment of non-small cell lung cancer has closed oa status in the ScholarIQ index.
What is the DOI of Pembrolizumab for the treatment of non-small cell lung cancer?
ScholarIQdoi
The DOI for Pembrolizumab for the treatment of non-small cell lung cancer is on the source record.
What is the OpenAlex record for Pembrolizumab for the treatment of non-small cell lung cancer?
ScholarIQopenalex
The OpenAlex for Pembrolizumab for the treatment of non-small cell lung cancer is on the source record.